Sam Altman and Dario Amodei are both walking back their AI jobs apocalypse prophecies as they eye blockbuster IPOs | Fortune
Two of the most influential CEOs in tech spent the last year warning that AI would gut white-collar employment. Now ...
Tag: blockbuster
Cerebras’ blockbuster IPO boosts hype for SpaceX and OpenAI, but crowds out smaller players
Andrew Feldman, co-founder and chief executive officer of Cerebras Systems Inc., center left, during the company's initial public offering (IPO) ...
Palantir’s blockbuster earnings fired a starting gun on a global rally in stocks | Fortune
A huge global rally in stocks is underway today after Palantir delivered yet another blockbuster earnings call that blew through ...
Shares of Chinese chipmaker MetaX soar nearly 700% in blockbuster Shanghai debut
Narumon Bowonkitwanchai | Moment | Getty ImagesShares of Chinese chipmaker MetaX Integrated Circuits soared nearly 700% in their market debut ...
Broadcom tumbles 11% despite blockbuster earnings as ‘AI angst’ weighs on Oracle, Nvidia
Broadcom CEO Hock Tan.Lucas Jackson | ReutersBroadcom's quarterly results and guidance sailed past Wall Street estimates. It didn't matter. The ...
Where the blockbuster weight loss drug market stands today — and what’s coming next
A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by ...
Tech industry insiders share their picks for the next startups to ride the IPO wave after Figma’s blockbuster debut
Figma’s sensational IPO last week resurrected longstanding debates about IPO pricing and first day pops—an unsurprising reaction to the newly ...
Meta vs. the FTC: The blockbuster antitrust trial kicks off
This photo illustration created on January 7, 2025, in Washington, DC, shows an image of Mark Zuckerberg, CEO of Meta, ...
Klarna scores global payment deal with Stripe to expand reach ahead of blockbuster U.S. IPO
"Buy-now, pay-later" firm Klarna aims to return to profit by summer 2023.Jakub Porzycki | NurPhoto | Getty ImagesKlarna has agreed ...
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSEBig pharmaceutical companies such as Bristol Myers ...
